Start with one research question
We welcome enquiries for a small, manually scoped pilot. We first agree the question, jurisdictions, source cutoff, output format and acceptance criteria. Availability and delivery are confirmed after scoping; there is no instant report, automated feed or live API subscription.
Evidence briefs
A source-linked reading brief separating molecule identity, study populations, endpoints, negative findings and unanswered questions. Useful as a starting point for an editorial or research team.
Editorial research
A claim-to-source table for an educational article, with conflicting findings, dates and missing context made visible. Your organisation retains responsibility for professional review and publication.
Structured information pilots
Discuss a bounded CSV or JSON deliverable of original annotations and source links. Field definitions, update responsibilities and permitted reuse must be agreed before delivery.
An example of the information structure
This is a format demonstration based on our published Tirzepatide profile, not a commissioned report or a newly completed clinical review. Open the profile to read the underlying evidence and its review date.
- Record
- tirzepatide · molecule identity
- Question
- Which conclusions apply to an exact product, population and jurisdiction?
- Evidence separation
- Regulatory record / human study / preclinical finding
- Source provenance
- Primary-source URL, publication date and date checked for each claim
- Limitations
- Unanswered questions, population boundaries and conflicting findings
- Reuse
- Original annotations only, subject to agreed scope; third-party rights remain with their owners
Editorial control stays with the evidence
PrimeCoreBio is source-based educational publishing. We do not currently have an external medical reviewer. Research output is not medical, legal or investment advice, clinical decision support, product authentication or a systematic review unless a separately agreed method supports that description.
Methodology (TH) · Editorial policy (TH)Sponsorship and reuse enquiries
Potential editorial sponsorships are considered separately from research conclusions. Any accepted placement must be labelled; sponsors cannot buy evidence grades, favourable findings, clinical endorsement or ranking links. Paid links must be marked as sponsored. We do not offer promotional placements for unapproved drugs or performance-enhancing drug sales.
Licensing discussions cover only material PrimeCoreBio owns or has permission to license. Linked studies, labels, figures, manufacturer images and third-party databases are not automatically included. We do not offer reader contact lists or personal visitor data as a data product.
Newsletter sponsorship and API licensing are development options, not services currently launched. No audience size, sponsor relationship or customer results are claimed here.
Tell us what decision the research should support
Include your organisation, research question, intended audience, jurisdictions, preferred format and deadline. Please do not send patient records, sensitive personal information or confidential documents in an initial enquiry. Email opens your own mail app; sending an enquiry does not subscribe you to a newsletter.
primecorebio@gmail.com ↗Questions about working together
Who is this for?
Publishers, research teams, agencies and organisational education teams that need traceable source organisation. Clinical or investment decisions require appropriately qualified professional review.
Can I buy access to an API or a complete licensed database now?
No. Structured information work is currently an enquiry-led pilot. API access, recurring updates and licensing rights must not be assumed from the public library.
Does sponsorship influence the evidence?
A sponsor cannot purchase a favourable conclusion or evidence grade. Accepted placements must be disclosed and paid links identified as sponsored.